NEGATIVE PRESSURE DEVICE
20190321524 ยท 2019-10-24
Inventors
Cpc classification
International classification
Abstract
A method and apparatus are disclosed for providing negative pressure at a wound site. The apparatus includes a negative pressure reservoir and a reservoir valve for selectively connecting the reservoir to a wound chamber at a wound site. In particular, but not exclusively, the present invention relates to an apparatus including a source of negative pressure which acts as a negative pressure reservoir to continually or repeatedly top up an applied negative pressure so that negative pressure applied at a wound site can be maintained within desired limits for a relatively long period of time.
Claims
1-30. (canceled)
31. A method of providing reduced pressure treatment to a tissue site, the method comprising: storing a negative pressure within a first reservoir with a pump; delivering a desired negative pressure from a second reservoir fluidically connected to the tissue site; and if a pressure within the second reservoir exceeds the desired negative pressure, reducing the pressure within the second reservoir by allowing fluid communication between the first reservoir and the second reservoir.
32. The method of claim 31 wherein the pump is a powered pump.
33. The method of claim 31 wherein storing a negative pressure comprises opening a valve to allow the flow of reduced pressure from the pump coupled to the first reservoir.
34. The method of claim 31 further comprising disallowing fluid communication between the first reservoir and the second reservoir in response to the pressure within the second reservoir reaching the desired negative pressure.
35. A method of providing reduced pressure treatment to a tissue site, the method comprising: storing a negative pressure within a first chamber with an external reduced-pressure source; delivering a desired therapy pressure from a second chamber having an outlet port to the tissue site; and if a pressure within the second chamber exceeds the desired therapy pressure, reducing the pressure within the second chamber by allowing fluid communication between the first chamber and the outlet port of the second chamber.
36. The method of claim 35 wherein the external reduced-pressure source is a powered pump.
37. The method of claim 35 wherein storing a negative pressure comprises coupling the external reduced-pressure source to the first chamber and opening a valve assembly to allow the flow of reduced pressure.
38. A reduced pressure treatment system comprising: a dressing adapted to be positioned at a tissue site; a first reservoir in fluid communication with the dressing and adapted to deliver a desired negative pressure to the tissue site; a second reservoir adapted to store a negative pressure that is less than the desired negative pressure; a passage adapted to provide fluid communication between the first reservoir and the second reservoir; a first valve positioned in the passage, the first valve adapted to close if a pressure in the first reservoir is less than or equal to the desired therapy pressure and to open if the pressure in the first reservoir exceeds the desired therapy pressure; and a second valve coupled to the second reservoir and adapted to be fluidly coupled to a pump to permit evacuation of the second reservoir to a more negative pressure.
39. The system of claim 38, wherein an operational negative pressure range is between about ?50 mm Hg and ?200 mm Hg.
40. The system of claim 38, wherein the pressure in the tissue site is about ?125 mm Hg.
41. The system of claim 38, wherein the pump is a powered pump.
42. A reduced pressure treatment system comprising: a dressing adapted to be positioned at a tissue site; a first chamber having an output port in fluid communication with the dressing and adapted to deliver a desired therapy pressure to the tissue site; a second chamber adapted to store a negative pressure that is less than the desired therapy pressure; a passage adapted to provide fluid communication between the first chamber and the second chamber; and a first valve operably associated with the passage to substantially reduce fluid communication through the passage if a pressure in the first chamber is less than or equal to the desired therapy pressure and to allow fluid communication through the passage if the pressure in the first chamber exceeds the desired therapy pressure; a second valve coupled to the second chamber and adapted to be fluidly coupled to an external reduced-pressure source to permit fluid flow out of the second chamber in response to a supplied pressure provided by the external reduced-pressure source that is less than the pressure in the second chamber.
43. The system of claim 42, wherein the supplied pressure is in a range of about ?50 mm Hg to about ?200 mm Hg.
44. The system of claim 42, wherein the supplied pressure is over ?100 mm Hg.
45. The system of claim 42, wherein the external reduced-pressure source is a powered pump.
46. A negative pressure wound therapy apparatus comprising: a first negative pressure reservoir configured to store a supply of negative pressure at a first level; a second negative pressure reservoir configured to store a supply of negative pressure at a second level, wherein the first and second negative pressure reservoirs are configured to be fluidicially connected to a wound in parallel.
47. The apparatus of claim 46 wherein the second level is greater than the first level.
48. The apparatus of claim 46 further comprising: a first valve configured to be in fluidic communication with the first negative pressure reservoir and a wound; and a second valve configured to be in fluidic communication with the second negative pressure reservoir and the wound.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Embodiments of the present invention will now be described hereinafter, by way of example only, with reference to the accompanying drawings in which:
[0018]
[0019]
[0020]
[0021]
[0022] In the drawings like reference numerals refer to like parts.
DETAILED DESCRIPTION OF SOME EXEMPLIFYING EMBODIMENTS
[0023]
[0024] As illustrated in
[0025] An aspiration conduit 15 is located through a pinched section 16 of the drape 11 so as to provide a sealed tubular conduit under the drape into the wound site. The wound packer and aspiration conduit thus cooperate to resist crushing under the levels of vacuum created at the wound site and permit transfer of wound exudates across the wound area to the aspiration conduit sealed to the flexible cover drape which extends over the wound.
[0026] The aspiration conduit may be a plain flexible tube, for example, having a single lumen therethrough and made from a plastics material compatible with raw tissue. However, the aspiration conduit may alternatively have a plurality of lumens therethrough to achieve specific objectives. A portion of the tube sited within the wound chamber may aptly have a structure to enable continued aspiration and evacuation of wound exudate without becoming constricted or blocked even at the high levels of negative pressure envisaged.
[0027] It is envisaged that the negative pressure range for the apparatus embodying the present invention may be between about ?50 mmHg and ?200 mmHg (note that these pressures are relative to normal ambient atmospheric pressure thus, ?200 mmHg would be around 560 mmHg in practical terms). Aptly, the pressure range may be between about ?75 mmHg and ?150 mmHg. Alternatively a pressure range of up to ?75 mmHg, up to ?80 mmHg or over ?80 mmHg can be used. Also aptly a pressure range of below ?75 mmHg could be used. Alternatively a pressure range of over ?100 mmHg could be used or over ?150 mmHg. Aptly the pressure of the wound chamber is between ?125 mmHg and ?20 mmHg. It will thus be appreciated that negative pressure is taken to mean a pressure that is less than ambient atmospheric pressure.
[0028] The aspiration conduit 15 thus has an end proximate to the dressing and wound site. At a distal end remote from the dressing and wound site the aspiration conduit is secured to a valve 17. This in turn is connected via a conduit to a negative pressure reservoir 18 and further control valve 19. A fluid communication path is thus established between the valve 19, negative pressure reservoir 18, reservoir valve 17 and wound chamber 14.
[0029] Whilst embodiments of the present invention will be described hereinafter by way of reference to a wound chamber 14 defined at a wound site under a drape it will be understood that certain embodiments of the present invention can be utilised to maintain a negative pressure in a wound chamber which is a rigid structure or partly rigid structure such as a cup device placed over a wound site.
[0030]
[0031] It will be understood that rather than containing many resilient beads one or more blocks of resilient material such as foam could be utilised within the reservoir body 20 to prevent collapse. It is advantageous that as a negative pressure established in the negative pressure reservoir 18 diminishes the filler expands so as to increase the volume in the reservoir. Aptly the filler material is selected so that expansion occurs over the whole range of pressures experienced in the negative pressure reservoir. This can be achieved by using a single resilient material having a characteristic which makes the filler expand over a broad pressure range or by providing filler materials of different materials. For example some of the beads 24 may be manufactured of a material which expands over a particular pressure range whilst other beads are manufactured of a different material which expands over a different pressure range.
[0032] Absorber material is aptly held in the negative pressure reservoir. The absorber material can be any type of material able to absorb wound exudate or other liquid being drawn from the wound site into the reservoir 18 through the aspiration tube 15 and reservoir valve 17. The absorber 25 is aptly an absorber gel such as ISOLYSEL?. The absorbent can be separated from the filler material (as shown) or be integral therewith. An added advantage of using such a gel matrix is that when exudate is stored excessive movement of the liquid is prevented such as slopping of the liquid. This also minimises bacterial growth and minimises odours.
[0033]
[0034] It will be appreciated that the various tubes are connected to the fluid reservoir via a fluid tight connection which might be either a tight friction fit or a fitting which requires some securing mechanism such as a jubilee clip or the like. Further examples of possible methods of connection may be adhesive, welding or use of a snap together connector for example as manufactured by Colder Products.
[0035] Returning to
[0036] Over time it is inherent that small leakage paths are formed between the drape 11 and surrounding tissue 13. Also it is possible that leakage paths are created around the pinched region 16 in the drape. As a result the negative pressure applied at the wound site degrades, that is to say becomes less negative over time. The negative pressure reservoir valve 17 is selected to open and close automatically responsive to a pressure difference between the pressure in the aspiration tube 15 and wound site and the tubing and negative pressure reservoir 18. As the negative pressure in the wound site increases the reservoir valve 17 opens providing a fluid communication path between the wound chamber and the negative pressure reservoir. The result is that the wound chamber pressure becomes more negative whilst the negativity of the negative pressure in the reservoir 18 reduces. Over time the valve 17 opens and closes continually or repeatedly so as to deplete the source of negative pressure in the reservoir. During this period of time the negative pressure applied at the wound site is maintained as much as possible within desired negative pressure ranges.
[0037] As a result the prolonged application of a reduced pressure is enabled at the tissue site in a convenient and cost effective manner. A safe reduced pressure of, for example, no greater than 200 mmHg below ambient atmospheric pressure is created and applied at the site of application. The valves connecting the reservoir to the wound site are fail safe and will only open when there is a loss of vacuum within the wound chamber. Furthermore the valves are selected so as to close when the pressure at the wound site reaches a desired target specified by the pressure valve manufacturer. Thus by connecting a high vacuum reservoir to a wound site via a pressure regulating valve the duration therapy can be prolonged in contrast to the prior art.
[0038] An example of a vacuum pressure regulation valve of a type suitable according to certain embodiments of the present invention is the VRD-ANB-CD vacuum regulator as supplied by Beswick Engineering?. It will be appreciated that other fluid flow control valves used to turn on and off a flow of fluid can be utilised according to certain embodiments of the present invention.
[0039]
[0040]
[0041] Series connection of negative pressure reservoirs is useful for the controlled delivery of vacuum to the wound chamber. Pressure surges can be avoided in the event of single valve failure.
[0042] It will be appreciated that a combination of series and parallel connected negative pressure reservoirs can be utilised according to certain embodiments of the present invention. Also that one, two or more negative pressure reservoirs can be utilised.
[0043] Throughout the description and claims of this specification, the words comprise and contain and variations of the words, for example comprising and comprises, means including but not limited to, and is not intended to (and does not) exclude other moieties, additives, components, integers or steps.
[0044] Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
[0045] Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith.